Minnelide
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Minnelide, covering 2017-03-06 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer [Phase 1]